Tepkinly 4 mg/0.8 ml, Konzentrat zur Herstellung einer Injektionslösung

7680691610011 CH-69161 Konzentrat zur Herstellung einer Injektionslösung
Tepkinly 4 mg/0.8 ml, Konzentrat zur Herstellung einer Injektionslösung
Tepkinly 4 mg/0.8 ml, Konzentrat zur Herstellung einer Injektionslösung
Tepkinly 4 mg/0.8 ml, Konzentrat zur Herstellung einer Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat zur Herstellung einer Injektionslösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
31/07/2026
Summary of Product Characteristics
Français
31/07/2026
Summary of Product Characteristics
Italien
31/07/2026

Detailed composition

Substance Quantity Type Category
epcoritamabum
4.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
sorbitolum
21.84 MG Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.48 MG Substance HBESI

Reimbursement information

Public price
CHF 565.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2025

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
69161
Drug name
Tepkinly 4 mg/0,8 ml, Injektionslösung
Galenic form
KOINJ
ATC Code
L01FX27
Authorization status
B
Dispensing category
A
First authorization
15/02/2024
Authorization expiration date
05/05/2027
IT Number
07.16.1.
Domain
Human medicine
Field of application
Diffuses grosszelliges B-Zell-Lymphom; Follikuläres Lymphom

Package details

Description (FR)
TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce
Description (DE)
TEPKINLY 4 mg/0,8 ml Durchstf 4 mg 1 Stk
Market launch
15/02/2024
Narcotic (BTM)
No

Other package sizes (1)

TEPKINLY 4 mg/0,8 ml falc perf 4 mg 1 pce
1 DUR
GTIN: 7680691610028
View
Buy us a coffee Explore the data